Iterum Therapeutics PLC Cash Flow Quality Index

Latest as of September 2021: -1.05x

Iterum Therapeutics PLC cash flow quality index. Iterum Therapeutics PLC (ITRM) has a Cash Flow Quality Index of -1.05x as of September 2021. Operating cash flow of $-3.91 Million is below net income of $3.74 Million, suggesting accrual-heavy earnings not yet converted to cash. See Iterum Therapeutics PLC (ITRM) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.05x

Operating CF / Net Income

Operating Cash Flow

$-3.91 Million

USD

Net Income

$3.74 Million

USD

Data as of

Sep 2021

Most recent filing

Iterum Therapeutics PLC Cash Flow Quality Index by Year (None–None)

Iterum Therapeutics PLC cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Iterum Therapeutics PLC. For the full cash flow conversion analysis, see ITRM cash flow conversion.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.